Association between EAT-Lancet diet adherence and cancer incidence/mortality: a systematic review and meta-analysis
Frontiers in Oncology · 01.06.2026 · 16
DOI: 10.3389/fonc.2026.1823812 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 01.06.2026. Verfasst von Xinhe Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cancer is a major threat to public health around the world. Diet is a key factor that we can change to help prevent it. This study explores the association between adherence to the EAT-Lancet diet and cancer incidence and mortality.
Methods
A systematic search was conducted across PubMed, Web of Science, Embase, and the Cochrane Library for cohort studies published from January 2019 to September 2025. In the primary analyses, we pooled adjusted hazard ratios (HRs) with 95% confidence intervals (95% CIs) for the association between EAT-Lancet diet adherence scores and cancer outcomes, prioritizing linear score-increment estimates and using categorical adherence contrasts only when linear estimates were unavailable. Subgroup analyses were performed by cancer type and adherence level; adherence-level subgroup analyses used categorical contrasts reported in the original studies. Sensitivity analysis and publication-bias assessment were conducted.
Results
A total of 15 cohort studies were included. In the primary analyses, higher EAT-Lancet diet adherence scores were linearly associated with lower overall cancer incidence and overall cancer mortality (incidence: HR = 0.90, 95% CI: 0.84-0.95, P<0.001; mortality: HR = 0.92, 95% CI: 0.90-0.95, P<0.001). The clearest site-specific associations were observed for lung cancer incidence (HR = 0.93, 95% CI: 0.90-0.95, P<0.001) and lung cancer mortality (HR = 0.94, 95% CI: 0.90-0.97, P<0.001). No statistically significant associations were observed for breast, prostate, or colorectal cancer incidence (P>0.05).
Conclusion
Higher EAT-Lancet diet adherence scores may be associated with lower overall cancer incidence and mortality, with the clearest association observed for lung cancer. These findings should be interpreted cautiously because of heterogeneity, residual confounding, and differences in adherence assessment across cohorts. Systematic review registration https://www.crd.york.ac.uk/prospero/ , identifier CRD420251141170.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
- Health Science Center, Ningbo University, Ningbo, Zhejiang, China.
- School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
- Department of Clinical Nutrition, The First People's Hospital of Pinghu, Jiaxing, Zhejiang, China.
Zitieren
APA
Li, X., Chen, J., Sun, Z., Ni, M., Fu, M., & Tang, Y. (2026). Association between EAT-Lancet diet adherence and cancer incidence/mortality: a systematic review and meta-analysis. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1823812
Vancouver
Li X, Chen J, Sun Z, Ni M, Fu M, Tang Y. Association between EAT-Lancet diet adherence and cancer incidence/mortality: a systematic review and meta-analysis. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1823812
BibTeX
@article{Li2026,
author = {Li, Xinhe and Chen, Jingqi and Sun, Zhanqi and Ni, Minyuan and Fu, Minmin and Tang, Yunshi},
title = {Association between EAT-Lancet diet adherence and cancer incidence/mortality: a systematic review and meta-analysis},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1823812}
}
EUVIMED